felbamate has been researched along with Dyskinesia, Drug-Induced in 1 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the catalepsy test, felbamate antagonized dopamine D2 receptor- but not D1 receptor-induced akinesia." | 1.29 | Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats. ( Kretschmer, BD, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kretschmer, BD | 1 |
1 other study available for felbamate and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.
Topics: Animals; Anticonvulsants; Antiparkinson Agents; Benzazepines; Catalepsy; Dopamine D2 Receptor Antago | 1994 |